OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Iruela-Arispe on the Dr. Paul Janssen Award Symposium

October 13th 2011

Dr. Luisa Iruela-Arispe from University of California, Los Angeles on the Dr. Paul Janssen Award Symposium

Dr. Scagliotti on the Future of Multiple Gene Profiles

October 12th 2011

Dr. Giorgio Scagliotti from the University of Turin Discusses the Future of Multiple Gene Profiles

Dr. Goy on Novel Therapies at the JTCC Conference

October 11th 2011

Dr. Andre Goy from John Theurer Cancer Center on Integrating Novel Therapies Into the JTCC Conference

Dr. Morrow Discusses the Z11 Trial Focus on Morbidity

October 11th 2011

Dr. Monica Morrow from Memorial Sloan-Kettering Cancer Center Discusses the Z11 Trial Focus on Morbidity

Dr. Tripathy Discusses Iniparib Trial Heterogeneity

October 11th 2011

Dr. Debu Tripathy from USC Norris Comprehensive Cancer Center Discusses Iniparib Trial Heterogeneity

Dr. Goy on the Upcoming Conference at the JTCC

October 10th 2011

Dr. Andre Goy from John Theurer Cancer Center on the Upcoming Conference at John Theurer Cancer Center

Dr. Wakelee on Using Lymph Nodes for Lung Cancer Staging

October 10th 2011

Dr. Heather Wakelee from Stanford Clinical Cancer Center on Using Lymph Nodes for Lung Cancer Staging

Dr. Scagliotti on Mechanisms of Resistance to EGFR TKIs

October 7th 2011

Dr. Giorgio V. Scagliotti from the University of Turin on Mechanisms of Resistance to EGFR TKIs

Dr. Mills on the Development of Combination Therapies

October 7th 2011

Dr. Gordon B. Mills from MD Anderson Cancer Center Discusses the Development of Combination Therapies

Dr. Langer Discusses the JMEN Maintenance Pemetrexed Trial

October 6th 2011

Dr. Corey J. Langer from Abramson Cancer Center Discusses the JMEN Maintenance Pemetrexed Trial

Dr. McDonald on the Continued Understanding of Bevacizumab

October 6th 2011

Dr. Donald McDonald from the UCSF Comprehensive Cancer Center on the Continued Understanding of Bevacizumab

Dr. Kernstine on Variation in Thoracic Surgery Outcomes

October 5th 2011

Dr. Kemp Kernstine from University of Texas, Southwestern Medical Center Discusses Variation in Thoracic Surgery Outcomes

Dr. Rugo on Proliferation as an Anti-Angiogenesis Marker

October 5th 2011

Dr. Hope S. Rugo from University of California, San Francisco on Proliferation as an Anti-Angiogenesis Marker

Joanna Morales on Common Cancer Related Legal Issues

October 5th 2011

Joanna Morales from the Cancer Legal Resource Center on Common Cancer Related Legal Issues

Dr. Morrow on the Z11 Trial Results Changing Practice

October 4th 2011

Dr. Monica Morrow from Memorial Sloan-Kettering Cancer Center on the Z11 Trial Results Changing Practice

Dr. Langer on Assessing Patient Populations in Trials

October 4th 2011

Dr. Corey J. Langer from Abramson Cancer Center on Assessing Patient Populations in Clinical Trials

Dr. O'Shaughnessy Describes the School of Breast Oncology

October 3rd 2011

Dr. Joyce A. O'Shaughnessy from the Baylor Sammons Cancer Center Describes the School of Breast Oncology

Dr. Mills Explains the Vulnerability of Cancer Cells

October 3rd 2011

Dr. Gordon Mills from MD Anderson Cancer Center Explains the Vulnerability of Cancer Cells

Dr. Morrow Describes the ACOSOG Z11 Trial

September 30th 2011

Dr. Monica Morrow from Memorial Sloan-Kettering Cancer Center Describes the ACOSOG Z11 Trial

Dr. Wakelee on Adjuvant Therapy Predictive Markers

September 30th 2011

Dr. Heather Wakelee from Stanford Clinical Cancer Center Discusses Adjuvant Therapy Predictive Markers